Dow Corning and PolyOne join forces to serve China healthcare market

Dow Corning's picture
Printer-friendly versionPrinter-friendly versionPDF versionPDF version


Dow Corning Corporation has appointed PolyOne Distribution as its distributor for medical grade silicone products in Greater China. The agreement is intended to expand the opportunities for manufacturers of healthcare products in the region to benefit from a wider range of

Dow Corning® brand specialty silicone products.

Both companies see strong potential in the Greater China region for growing their respective businesses and meeting customer and patient needs in drug delivery, medical devices and pharmaceutical and biopharmaceutical processing. According to McKinsey, Greater China is among the world’s most attractive markets for healthcare as a result of urbanization, increasing income, social reform and the Government’s focus on healthcare within the 12th Five Year Plan.

The addition of Dow Corning® brand silicones to the PolyOne Distribution portfolio broadens the ability of both companies to support healthcare customers in China. PolyOne will offer a single channel for thermoplastic and thermoset resins used in medical applications. Customers will also gain from expanded healthcare-focused resources to accelerate product development and regulatory compliance.

“This agreement with Dow Corning strengthens our portfolio to better serve our healthcare customers located in China, and also supports our strategy of helping US-based multinational companies facilitate manufacturing in Asia,” stated Kurt Schuering, president, PolyOne Distribution.

“Dow Corning has many years of experience of working in China to support locally companies and multinationals in the medical device and pharmaceutical sectors with our expertise and silicone materials,” said Vincent Chang, Dow Corning’s healthcare commercial manager for Asia. “As China has grown, we’ve seen how the needs have also grown for more effective and safer materials to improve patient care and the quality of life. Our agreement with PolyOne Distribution will enable us to demonstrate the benefits of silicone materials to an even greater number of companies, particularly those USA companies that have facilities in China.”

The versatility of silicones make them suitable for a wide range of healthcare applications such as medical adhesives, tubing for drug delivery systems or Active Pharmaceutical Ingredients (API), for use in over-the-counter (OTC) antiflatulent or antigas products.  Dow Corning silicones for healthcare come in many forms:

About Dow Corning
Dow Corning (dowcorning.com) provides performance-enhancing solutions to serve the diverse needs of more than 25,000 customers worldwide. A global leader in silicones, silicon-based technology and innovation, Dow Corning offers more than 7,000 products and services via the company’s Dow Corning®  and XIAMETER® brands. Dow Corning has more than 60years of experience  in healthcare-related industries, working to improve the quality of life, transform patient care, and pioneer next generation innovation through silicone advancements. Dow Corning materials are designed for use in medical device fabrication including wound and scar management

drug delivery systems and pharmaceutical and biopharmaceutical processing.

Follow Dow Corning on Twitter:


Visit Dow Corning's YouTube channel: www.YouTube.com/dowcorningcorp

About PolyOne
PolyOne Corporation, with 2013 revenues of $3.8 billion, is a premier provider of specialized polymer materials, services and solutions. The company is dedicated to serving customers in diverse industries around the globe, by creating value through collaboration, innovation and an unwavering commitment to excellence. Guided by its Core Values, Sustainability Promise and No Surprises PledgeSM, PolyOne is committed to its customers, employees, communities and shareholders through ethical, sustainable and fiscally responsible principles. For more information, visit www.polyone.com.

News Source : Dow Corning and PolyOne join forces to serve China healthcare market

Copy this html code to your website/blog to embed this press release.